(Q34212165)

31 July 2017

1 reference

title

Polycystic ovary syndrome. A diagnostic challenge (English)

1 reference

polycystic ovary syndrome

31 July 2017

1 reference

1 reference

Lewis V

1

1 reference

31 July 2017

1 March 2001

1 reference

Obstetrics and Gynecology Clinics of North America

31 July 2017

1 reference

31 July 2017

28

1 reference

31 July 2017

1-20

1 reference

31 July 2017

1

1 reference

Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Prevalence of hyperandrogenemia among nonhirsute oligo-ovulatory women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Clinical review 56: Nonclassic adrenal hyperplasia: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Role of the ovary in the adrenal androgen excess of hyperandrogenic women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: A common endocrinopathy with distinct pathophysiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The role of color doppler imaging in the diagnosis of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Relation of luteinizing hormone levels to body mass index in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Measurement of total serum testosterone levels using commercially available kits: high degree of between-kit variability.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Ovarian stromal echogenicity in women with normal and polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Virilizing adrenal carcinoma in a woman of reproductive age: a case presentation and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Hereditary factors in the Stein-Leventhal syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Identification of virilizing adrenal tumors in hirsute women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The diagnosis of polycystic ovaries in subfertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The significance of a single serum LH measurement in women with cycle disturbances: discrepancies between immunoreactive and bioactive hormone estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Transvaginal ultrasound appearances of the ovary in normal women and hirsute women with oligomenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Serum testosterone concentrations in the evaluation of androgen-producing tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Oestradiol feedback stimulation of androgen biosynthesis by human theca cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Multiple Androgenic Abnormalities, Including Elevated Free Testosterone, in Hyperprolactinemic Women*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Disturbances of menstruation in hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The genetics of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovary syndrome: current and future treatment paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The control of bioactive luteinizing hormone secretion in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovaries and associated clinical and biochemical features in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Non-classic adrenal hyperplasia in hyperandrogenism: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Clinical and hormonal studies in hyperthecosis of the ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Increased expression of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage and P450 17alpha-hydroxylase enzymes in ovarian hyperthecosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Hyperinsulinemia in hyperthecosis of the ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

How to discriminate between normal and polycystic ovaries: transvaginal US study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovaries--a common finding in normal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

The difference in miscarriage rates between menotropin-induced and natural cycle pregnancies is not surveillance related

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Which hormone tests for the diagnosis of polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Cancer incidence in a cohort of infertile women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Prevalence of acanthosis nigricans in an unselected population

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Medical implications of ultrasonically detected polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Morphological assessment of polycystic ovary using transvaginal ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Warning on serum testosterone measurement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

An evaluation of 13 commercial kits for the measurement of testosterone in serum and plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Inappropriate Secretion of Follicle-Stimulating Hormone and Luteinizing Hormone in Polycystic Ovarian Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

Ovarian stromal blood flow in women with polycystic ovaries--a possible new marker for diagnosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970182-0

7 January 2021

10.1016/S0889-8545(05)70182-0

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11292997